DANS-APP: Rhythm Effect on Dance Learning in Children With and Without Cerebral Palsy.

Sponsor
University Hospital, Toulouse (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT06137625
Collaborator
(none)
68
2
36

Study Details

Study Description

Brief Summary

Cerebral Palsy (CP) leads to motor impairments and impacts activities of daily living and academic and social achievement (American Psychiatric Association, 2013). Children with CP present impaired procedural learning abilities that is the ability to acquire cognitive-motor skills with practice (Gagliardi et al., 2011; Gofer-Levi et al., 2013). However, some rehabilitative rhythmic interventions, such as adaptive dance training, appear to improve motor, cognitive, psycho-emotional, and social functions in these children (Cherriere, Martel, et al., 2020; Cherriere, Robert, et al., 2020). Rhythm seems to be an important factor in these benefits, probably because regular rhythm improves motor control and learning (Thaut, 2015; Lagarrigue et al., 2021; Ghai et al., 2022). To validate this hypothesis, the investigators propose to evaluate the effects the presence of a regular rhythm on learning of a danse choreography in typically developing children and children with CP.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: With regular rhythm
  • Behavioral: Without regular rhythm
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
68 participants
Allocation:
Randomized
Intervention Model:
Crossover Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Basic Science
Official Title:
Rhythm Effect on Dance Learning and Associated Functions in Typical Development Children and Children With Cerebral Palsy.
Anticipated Study Start Date :
Jan 1, 2024
Anticipated Primary Completion Date :
Jan 1, 2027
Anticipated Study Completion Date :
Jan 1, 2027

Arms and Interventions

Arm Intervention/Treatment
Experimental: Cerebral Palsy

Children with Cerebral Palsy

Behavioral: With regular rhythm
All children learn one dance choreographie with regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Behavioral: Without regular rhythm
All children learn one dance choreographie without regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Active Comparator: Typical developing

Typical developing children

Behavioral: With regular rhythm
All children learn one dance choreographie with regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Behavioral: Without regular rhythm
All children learn one dance choreographie without regular rhythm music.The pre-recorded choreography is displayed on a large screen in front of the child. The child practices the choreography by imitating the models in order to learn the sequence movements.

Outcome Measures

Primary Outcome Measures

  1. Retention score of the choreography [Day 0]

    Number of movements in the choreography performed correctly and in order after practice is analysed by video using a standardised observation grid scored independently and blind to the condition by two trained judges.

Secondary Outcome Measures

  1. the effect of regular rhythm on Perceptivo-Motor Procedural Learning (PMPL) [Day 0]

    The PMPL is measured by an informatised and standardised test (EVAL_App_Kids test)

  2. the effect of regular rhythm on sensorimotor function [Day 0]

    the effect is measured by rhythm perception and production task

  3. the effect of regular rhythm on cognitive function [Day 0]

    the effect is measured by informatised test on attention and executive function

  4. the effect of regular rhythm on psychoaffective function [Day 0]

    the effect is measured by questionary Physical Activity Enjoyment Scale (PACES)

Eligibility Criteria

Criteria

Ages Eligible for Study:
8 Years to 16 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
For all the participants:
  • Aged from 8 to 16 include.

  • Free, informed, written, and signed consent of the holders of parental authority

  • Free and informed consent of the minor

  • Affiliation with or benefiting from a social security scheme.

  • Ability to understand the instructions (investigator's assessment)

For the participant with CP:
  • CP diagnosis

  • Gross Motor Function Classification System level between I to IV.

  • Manual Ability Classification System level between I to IV.

For the participant with typical development:
  • No CP diagnosis

  • No neurological trouble nor functional disfunction including developmental coordination disorder.

Exclusion Criteria:
  • -Autism spectrum disorder diagnosed according to the DSM-5 (APA, 2015)

  • Hearing deficiency diagnosed according to the DSM-5 (APA, 2015) or uncorrected hearing deficiency that doesn't allows the participant to hear a music with a sound level between 45 and 70 decibels.

  • Visual deficiency diagnosed according to the DSM-5 (APA, 2015)

  • Intellectual developmental disorder diagnosed according to the DSM-5 (APA, 2015)

  • Behavioural disorders diagnosed according to the DSM-5 (APA, 2015)

  • Diagnosed epilepsia

  • Pregnancy (check in young pubescent and sexually active women) or breastfeeding.

  • Children already include in ongoing interventional study.

  • Children with both parent who benefit of legal protection (guardianship, curatorship, safeguard of justice).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • University Hospital, Toulouse

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University Hospital, Toulouse
ClinicalTrials.gov Identifier:
NCT06137625
Other Study ID Numbers:
  • RC31/22/0039
  • ANR-21-CE28-0031
First Posted:
Nov 18, 2023
Last Update Posted:
Nov 18, 2023
Last Verified:
Nov 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 18, 2023